Skip to main content

Table 3 In-hospital outcomes between SLE and matched-control patients*

From: The impact of systemic lupus erythematosus on the risk of infection after total hip arthroplasty: a nationwide population-based matched cohort study

  SLE Control P
(n = 325) (n = 325)
Pneumonia 0 (0.0%) 0 (0.0%) 1.00
Urinary tract infection 6 (2.5%) 7 (2.6%) 0.94
Pulmonary embolism 0 (0.0%) 0 (0.0%) 1.00
Sepsis 0 (0.0%) 0 (0.0%) 1.00
Deep vein thrombosis 1 (0.3%) 0 (0.0%) 0.31
In-hospital mortality 0 (0.0%) 0 (0.0%) 1.00
  1. SLE systemic lupus erythematosus
  2. *Data are presented as number and percentage